Wolters Kluwer acquires online healthcare courseware provider IntelliLearn

30.05.25 14:00 Uhr

Werte in diesem Artikel
Aktien

156,35 EUR -3,65 EUR -2,28%

PRESS RELEASE

Wolters Kluwer acquires online healthcare courseware provider IntelliLearn

Wer­bung

Waltham May 30, 2025 Wolters Kluwer Health today announced it has acquired IntelliLearn Pty Ltd., a provider of online courseware solutions for nursing schools in Australia and the U.S.

IntelliLearn will become part of Wolters Kluwer’s Health, Learning, Research & Practice (HLRP) business, a leader in nursing education and practice solutions.

"We’re pleased to be adding the IntelliLearn solutions to our Lippincott suite of nursing products,” said Julie Stegman, Vice President and General Manager, Wolters Kluwer Health, Learning & Practice. "The IntelliLearn solutions, including medication safety and other medical math content, allow us to offer an even broader range of training modules to prepare nursing students for practice.”

Founded in 2010 and based in Adelaide, Australia, IntelliLearn’s cloud-based solutions are used by educational institutions in Australia, New Zealand, Canada, and the U.S. The company brings seven full-time employees to Wolters Kluwer Health as well as a network of contract workers. The acquisition is expected to reach a return on invested capital (ROIC) above our weighted after-tax cost of capital (WACC) within three to five years and to have an immaterial impact on Wolters Kluwer adjusted earnings.

Wer­bung

###
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,900 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50 and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wer­bung

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

MediaInvestors/Analysts
Stefan KloetMeg Geldens
Associate DirectorVice President
Global CommunicationsInvestor Relations
  
press@wolterskluwer.comir@wolterskluwer.com
m: +31 612 223 657 

Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as "expect”, "should”, "could”, "shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by pandemics; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Attachment


Ausgewählte Hebelprodukte auf Wolters Kluwer

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Wolters Kluwer

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Wolters Kluwer N.V.

Wer­bung

Analysen zu Wolters Kluwer N.V.

DatumRatingAnalyst
12.05.2025Wolters Kluwer BuyGoldman Sachs Group Inc.
09.05.2025Wolters Kluwer NeutralUBS AG
07.05.2025Wolters Kluwer BuyUBS AG
14.04.2025Wolters Kluwer Market-PerformBernstein Research
10.04.2025Wolters Kluwer HoldDeutsche Bank AG
DatumRatingAnalyst
12.05.2025Wolters Kluwer BuyGoldman Sachs Group Inc.
07.05.2025Wolters Kluwer BuyUBS AG
26.03.2025Wolters Kluwer BuyGoldman Sachs Group Inc.
20.03.2025Wolters Kluwer BuyUBS AG
26.02.2025Wolters Kluwer BuyUBS AG
DatumRatingAnalyst
09.05.2025Wolters Kluwer NeutralUBS AG
14.04.2025Wolters Kluwer Market-PerformBernstein Research
10.04.2025Wolters Kluwer HoldDeutsche Bank AG
27.02.2025Wolters Kluwer HoldDeutsche Bank AG
27.02.2025Wolters Kluwer NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
28.07.2011Wolters Kluwer sellCitigroup Corp.
12.05.2005Wolters Kluwer: Underweight JP Morgan
10.05.2005Wolters Kluwer: Underperform Goldman Sachs
04.03.2005Wolters Kluwer: Underperform Goldman Sachs
24.01.2005Wolters Kluwer: UnderweightJP Morgan

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Wolters Kluwer N.V. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen